Cloud Pathology Group Competitors

Driven by knowledge and passion, our vision is to contribute to a healthier and safer society. With solutions and services for medical imaging IT and cybersecurity, Sectra helps hospitals worldwide to enhance the efficiency of care, and critical social functions, authorities and defense forces in Europe to protect society’s most sensitive information. The company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. The Sectra share (SECT B) is quoted on the Nasdaq Stockholm exchange. Career at Sectra: https://career.sectra.com/ Investor Relations: https://investor.sectra.com/ Imaging IT Solutions Medical images play a key role in diagnostics and the determination of an appropriate treatment. We develop future-proof and effective IT solutions and services for storing, viewing and working with medical images. Cancer diseases, osteoarthritis and orthopaedic surgery represent some of the costliest and resource-intensive areas in the healthcare sector—areas where our offering supports diagnosis, planning, and patient monitoring, as well as helps various departments and disciplines cooperate for better and more efficient care. We also help raise the quality of medical education by providing solutions for sharing and interacting with medical images. For more information: https://medical.sectra.com/ Secure Communications The secure transfer of information plays a key role in maintaining the stability in many of society’s functions. We develop products and services that increase cybersecurity by protecting some of society’s most sensitive information and communications. The offering includes secure voice and data communications, with solutions certified at national levels and by the EU and NATO, as well as security analysis and monitoring of critical IT systems, such as electricity and water supply. For more information: https://communications.sectra.com/

Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options. Learn more about Paige: https://www.paige.ai

From discovery to diagnosis, the HALO® suite supports the full digital pathology journey. Indica Labs delivers AI-powered solutions spanning life science research, translational science, pharmaceutical development, companion diagnostics, and clinical deployment. Today, HALO has surpassed 3,000 deployments across 35 countries and six continents, supporting all 20 of the world’s top pharmaceutical companies and research cited in more than 2,600 peer-reviewed publications. That global research footprint is increasingly translating into clinical adoption, with HALO AP® clinical revenue growing 260% since 2023 and recurring clinical revenue increasing 200% year-over-year in 2025. From HALO®, HALO AI, and HALO Link to HALO AP® (CE-IVDR marked) and HALO AP Dx (FDA 510k cleared), one connected ecosystem helps bridge discovery, development, validation, and clinical implementation. One HALO ecosystem. From life science discovery to clinical deployment.